Rockefeller Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.8M Buy
280,882
+23,656
+9% +$2.51M 0.07% 277
2025
Q1
$31.9M Buy
257,226
+6,816
+3% +$846K 0.08% 243
2024
Q4
$30.8M Buy
250,410
+4,006
+2% +$493K 0.08% 240
2024
Q3
$27.5M Buy
246,404
+3,307
+1% +$368K 0.07% 256
2024
Q2
$25.9M Buy
243,097
+148,691
+158% +$15.9M 0.07% 249
2024
Q1
$11.4M Buy
94,406
+15,413
+20% +$1.86M 0.03% 464
2023
Q4
$9.72M Buy
78,993
+19,946
+34% +$2.45M 0.03% 469
2023
Q3
$7.64M Buy
59,047
+1,944
+3% +$252K 0.03% 488
2023
Q2
$7.08M Buy
57,103
+18,801
+49% +$2.33M 0.03% 521
2023
Q1
$5.6M Sell
38,302
-508
-1% -$74.3K 0.02% 546
2022
Q4
$6.18M Buy
38,810
+1,758
+5% +$280K 0.03% 487
2022
Q3
$4.94M Sell
37,052
-338
-0.9% -$45K 0.03% 538
2022
Q2
$5.83M Sell
37,390
-11,602
-24% -$1.81M 0.03% 478
2022
Q1
$7.63M Sell
48,992
-3,532
-7% -$550K 0.04% 438
2021
Q4
$6.69M Buy
52,524
+23,107
+79% +$2.94M 0.03% 461
2021
Q3
$3.83M Buy
29,417
+13,324
+83% +$1.73M 0.02% 555
2021
Q2
$2.86M Buy
16,093
+9,957
+162% +$1.77M 0.02% 624
2021
Q1
$1.01M Buy
6,136
+54
+0.9% +$8.87K 0.01% 780
2020
Q4
$1M Sell
6,082
-1,022
-14% -$169K 0.01% 689
2020
Q3
$1.01M Hold
7,104
0.01% 594
2020
Q2
$784K Sell
7,104
-100
-1% -$11K 0.01% 594
2020
Q1
$718K Sell
7,204
-944
-12% -$94.1K 0.01% 540
2019
Q4
$1.22M Buy
8,148
+40
+0.5% +$5.97K 0.02% 417
2019
Q3
$1.04M Buy
8,108
+322
+4% +$41.3K 0.01% 384
2019
Q2
$1.11M Buy
7,786
+496
+7% +$70.7K 0.02% 331
2019
Q1
$1.04M Buy
7,290
+3,230
+80% +$462K 0.01% 368
2018
Q4
$503K Buy
+4,060
New +$503K 0.01% 321